Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q3 FY25 results · Oct–Dec 2024
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,247.63 crore (up 10.1% from Q3 FY24) and net profit of ₹268.59 crore (up 17.3% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a standalone basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,247.63 | 1,133.43 | +10.1% | 1,135.16 | +9.9% |
| Other income | 9.71 | 15.58 | −37.7% | 8.50 | +14.2% |
| Total income | 1,257.34 | 1,149.01 | +9.4% | 1,143.66 | +9.9% |
| Profit before tax | 364.13 | 308.51 | +18.0% | 285.37 | +27.6% |
| Net profit for the period | 268.59 | 228.90 | +17.3% | 211.90 | +26.8% |
| EPS, basic (₹) | 82.74 | 70.51 | +17.3% | 65.28 | +26.7% |
| Net margin (%) | 21.5 | 20.2 | 18.7 |
Standalone
- Filed with BSE
- 11 Feb 2025, 18:58 IST
- Board meeting
- 02 Nov 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE